Robert Johnson
Visionary · DISC type DsRobert Johnson is the CEO of Kesmalea Therapeutics, focusing on developing small molecule protein degraders. He is a seasoned biotech executive with a track record of founding and leading companies, including Adrestia Therapeutics, which he sold to Insmed. Colleagues describe him as professional, creative, tenacious, and an astute negotiator.
Outside of work, Robert is a dedicated runner and fundraiser. He recently completed the London Marathon to raise money and awareness for the Ataxia Telangiectasia Society, a charity supporting children and families affected by a rare and complex genetic condition that causes severe disability.
He ran his first marathon to raise funds for research into Ataxia Telangiectasia, a rare disease his former company was working to treat.
Read the full overview →How Robert shows up
They are very professional in their approach and can weigh multiple perspectives together. They might take some time to make their mind up but once they do, they don't change it easily. Reading between the lines and seeing beyond your words comes naturally to them.
Topics Robert cares about
Work history
Media appearances
DISC profile (public)
Dominance (D)
Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.